Relapse after anti-CD19 CAR T-cell therapy in a patient with severe rheumatoid arthritis and multiple sclerosis effectively treated by autologous stem cell transplantation

Affiliations

¹ Department for Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tuebingen, Tuebingen, Germany.
² Department of Neurology and Stroke, Center for Neurology, and Hertie-Institute for Clinical Brain Research Eberhard-Karls, University of Tuebingen, Tuebingen, Germany.
³ Diagnostic and Interventional Neuroradiology, Department of Radiology, University Hospital Tuebingen, Tuebingen, Germany.
⁴ Department for Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tuebingen, Tuebingen, Germany. Electronic address: joerg.henes@med.uni-tuebingen.de.

Ann-Christin Pecher et al. Ann Rheum Dis. 2025 Jul.

. 2025 Jul;84(7):1284-1286.

doi: 10.1016/j.ard.2025.03.018. Epub 2025 May 1.

¹ Department for Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tuebingen, Tuebingen, Germany.
² Department of Neurology and Stroke, Center for Neurology, and Hertie-Institute for Clinical Brain Research Eberhard-Karls, University of Tuebingen, Tuebingen, Germany.
³ Diagnostic and Interventional Neuroradiology, Department of Radiology, University Hospital Tuebingen, Tuebingen, Germany.
⁴ Department for Internal Medicine II (Hematology, Oncology, Rheumatology and Clinical Immunology), University Hospital Tuebingen, Tuebingen, Germany. Electronic address: joerg.henes@med.uni-tuebingen.de.

No abstract available

Conflict of interest statement

Declaration of competing interest The authors declare they have no competing interests.